GLP1R and obesity due to melanocortin 4 receptor deficiency: More recently, because of the appetite inhibiting effects of GLP-1, GLP-1 based therapies have been approved for treatment of obesity and currently represent the most efficacious pharmacological therapy for weight loss (12).